In:
The Oncologist, Oxford University Press (OUP), Vol. 26, No. 2 ( 2021-02-01), p. e347-e349
Abstract:
This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID-19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID-19 infection.
Type of Medium:
Online Resource
ISSN:
1083-7159
,
1549-490X
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2021
detail.hit.zdb_id:
2023829-0